Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab Plus FLOT vs SOX in Locally Advanced Gastric Cancer
NCT06459921Phase 2Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Dec 2024
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of sintilimab in gastric cancer (GC), sponsored by Xijing Hospital. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
sintilimab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06459921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06459921.